Absci Corp (ABSI)
5.225
+0.14
(+2.85%)
USD |
NASDAQ |
May 06, 15:43
Absci Total Liabilities (Quarterly): 41.12M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 41.12M |
| September 30, 2023 | 39.93M |
| June 30, 2023 | 38.75M |
| March 31, 2023 | 41.84M |
| December 31, 2022 | 46.59M |
| September 30, 2022 | 46.44M |
| June 30, 2022 | 50.12M |
| Date | Value |
|---|---|
| March 31, 2022 | 54.96M |
| December 31, 2021 | 60.09M |
| September 30, 2021 | 61.11M |
| June 30, 2021 | 219.96M |
| March 31, 2021 | 321.34M |
| December 31, 2020 | 178.00M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
38.75M
Minimum
Jun 2023
321.34M
Maximum
Mar 2021
92.33M
Average
50.12M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Amgen Inc | 87.96B |
| Creative Medical Technology Holdings Inc | 0.3714M |
| CytomX Therapeutics Inc | 249.24M |
| HOOKIPA Pharma Inc | 71.48M |
| Recursion Pharmaceuticals Inc | 190.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 217.30M |
| Shareholders Equity (Quarterly) | 176.18M |
| Debt to Equity Ratio | 0.0449 |
| Current Ratio | 4.079 |
| Net Debt Paydown Yield | 0.05% |